FDA Approves Penpulimab-kcqx for Non-keratinizing Nasopharyngeal Carcinoma By Ogkologos - May 23, 2025 522 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study AK105-304 and Study AK105-202 Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian Patient Guide in Bladder Cancer Now Available Also in French Clinical Activity of Elraglusib with Gemcitabine Plus Nab-paclitaxel in First-Line Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma MOST POPULAR Foodie Friday: It’s Berry Season! July 30, 2021 Perioperative Treatment with Nivolumab Results in Significantly Longer Event-Free Survival than... May 22, 2024 Invasive Lobular Carcinoma Is Invisible On Mammograms, Isn’t A Lump April 4, 2019 Safety and Preliminary Signs of Activity of OMO-103, a MYC Inhibitor,... February 9, 2024 Load more HOT NEWS Dogs Can Sniff Out COVID-19 After Just One Week Of Training,... Extended Anticoagulation with Reduced-Dose Non-inferior to Full-Dose Apixaban for the Prevention... EMA Recommends to Extend Therapeutic Indications for Crizotinib in Paediatric Patients The American Society of Clinical Oncology and the American Cancer Society:...
